A sirolimus-eluting biodegradable polymer stent versus a dual sirolimus- and probucol-eluting polymer-free stent in Chinese patients with obstructive coronary artery disease

Trial Profile

A sirolimus-eluting biodegradable polymer stent versus a dual sirolimus- and probucol-eluting polymer-free stent in Chinese patients with obstructive coronary artery disease

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Feb 2013

At a glance

  • Drugs Sirolimus (Primary) ; Probucol
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms DKPLUS-Wave 1
  • Most Recent Events

    • 08 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top